在全身性红血性狼的临床谱中的差异补充路径和组件
Haijun Ma1,2, Qingfeng Yin3, Huifang Li4
1Department of Rheumatology and Immunology, The First Affiliated Hospital of Xinxiang Medical University, 88 Jiankang Road, Weihui, Henan, 453100, China. haijunma97@hotmail.com.
Arthritis research & therapy
|December 26, 2025
概括
经典途径在全身性红斑狼 (SLE) 的早期被激活,而替代途径驱动疾病的进展. 补充成分C2和D因子可以作为SLE并发症的生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 补充系统 补充系统
背景情况:
- 系统性红斑狼 (SLE) 的发病过程涉及复杂的免疫失调.
- 在SLE中,古典 (CP),莱克 (LP) 和替代 (AP) 补充途径的作用尚未完全阐明.
研究的目的:
- 在SLE患者中全面研究补充路径组件.
- 确定SLE活动和并发症的潜在生物标志物.
主要方法:
- 多重测定用于测量60名SLE患者和20名健康对照组 (HC) 中各种补充成分 (C1q,C4,C4b,C2,C3,C5,FB,FP,FD,FH,FI,MBL) 的血水平.
- 进行了包括回归和主要成分分析在内的统计分析.
主要成果:
- 活跃的SLE显示C1q,C4,C4b,C3和FP下降,与HC和低疾病活性组相比,C2增加.
- 较低的C3和C4水平与较高的抗dsDNA,增加的C2和新诊断的SLE相关.
- C2与同时感染独立相关,FD与功能呈负相关性.
结论:
- CP主要在SLE发病时被激活,而AP则对启动和进展都有贡献.
- 补充成分C2和D因子显示出作为SLE并发症生物标志物的潜力.
- 基于补充的患者分层可能会指导SLE的精度治疗.
相关概念视频
Complement System
9.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.5K
Complementation Tests
6.0K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.0K
Antigen Processing Pathways
2.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.0K
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K


